IL27RA and graft versus host disease: Recipients that received T cells deficient for IL-27Rα developed less severe GVHD, as shown by a significantly higher survival percentage across experiments compared to WT controls (Figure 1A); which correlated with significantly improved body weight maintenance among groups that received IL-27Rα deficient T cells (Figure 1B).